Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Nature Methods
|
August 16, 2016
Single-cell multimodal profiling reveals cellular epigenetic heterogeneity
Lih Feng Cheow, Elise T Courtois, Yuliana Tan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 10, 2024
Single-cell analysis identifies distinct macrophage phenotypes associated with prodisease and proresolving functions in the endometriotic niche
Yasmin Henlon, Kavita Panir, Iona McIntyre, et al.
Clinical Chemistry
|
December 8, 2018
Concurrent Single-Cell RNA and Targeted DNA Sequencing on an Automated Platform for Comeasurement of Genomic and Transcriptomic Signatures
Say Li Kong, Huipeng Li, Joyce A Tai, et al.
Oncoimmunology
|
May 5, 2020
Antibody targeting of B7-H4 enhances the immune response in urothelial carcinoma
Joseph R Podojil, Alexander P Glaser, Dylan Baker, et al.
Nature Genetics
|
March 21, 2017
Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors
Huipeng Li, Elise T Courtois, Debarka Sengupta, et al.
Nature Genetics
|
November 14, 2018
Author Correction: Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors
Huipeng Li, Elise T Courtois, Debarka Sengupta, et al.
Biorxiv : the Preprint Server for Biology
|
July 29, 2024
Mapping the genetic landscape establishing a tumor immune microenvironment favorable for anti-PD-1 response in mice and humans
Daniel A Skelly, John P Graham, Mingshan Cheng, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 17, 2024
Single nucleus transcriptomics, pharmacokinetics, and pharmacodynamics of combined CDK4/6 and mTOR inhibition in a phase 0/1 trial of recurrent high-grade glioma
Kevin C Johnson, An-Chi Tien, Jun Jiang, et al.
Cell Reports
|
May 9, 2025
Mapping the genetic landscape establishing a tumor immune microenvironment favorable for anti-PD-1 response
Daniel A Skelly, John P Graham, Mingshan Cheng, et al.
Neuro-Oncology
|
November 9, 2025
Single nucleus transcriptomics, pharmacokinetics, and pharmacodynamics of CDK4/6 and mTOR inhibition in a phase 0/1 trial of recurrent high-grade glioma
Kevin C Johnson, An-Chi Tien, Jun Jiang, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Nature Methods
|
August 16, 2016
Single-cell multimodal profiling reveals cellular epigenetic heterogeneity
Lih Feng Cheow, Elise T Courtois, Yuliana Tan, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 10, 2024
Single-cell analysis identifies distinct macrophage phenotypes associated with prodisease and proresolving functions in the endometriotic niche
Yasmin Henlon, Kavita Panir, Iona McIntyre, et al.
Clinical Chemistry
|
December 8, 2018
Concurrent Single-Cell RNA and Targeted DNA Sequencing on an Automated Platform for Comeasurement of Genomic and Transcriptomic Signatures
Say Li Kong, Huipeng Li, Joyce A Tai, et al.
Oncoimmunology
|
May 5, 2020
Antibody targeting of B7-H4 enhances the immune response in urothelial carcinoma
Joseph R Podojil, Alexander P Glaser, Dylan Baker, et al.
Nature Genetics
|
March 21, 2017
Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors
Huipeng Li, Elise T Courtois, Debarka Sengupta, et al.
Nature Genetics
|
November 14, 2018
Author Correction: Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors
Huipeng Li, Elise T Courtois, Debarka Sengupta, et al.
Biorxiv : the Preprint Server for Biology
|
July 29, 2024
Mapping the genetic landscape establishing a tumor immune microenvironment favorable for anti-PD-1 response in mice and humans
Daniel A Skelly, John P Graham, Mingshan Cheng, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 17, 2024
Single nucleus transcriptomics, pharmacokinetics, and pharmacodynamics of combined CDK4/6 and mTOR inhibition in a phase 0/1 trial of recurrent high-grade glioma
Kevin C Johnson, An-Chi Tien, Jun Jiang, et al.
Cell Reports
|
May 9, 2025
Mapping the genetic landscape establishing a tumor immune microenvironment favorable for anti-PD-1 response
Daniel A Skelly, John P Graham, Mingshan Cheng, et al.
Neuro-Oncology
|
November 9, 2025
Single nucleus transcriptomics, pharmacokinetics, and pharmacodynamics of CDK4/6 and mTOR inhibition in a phase 0/1 trial of recurrent high-grade glioma
Kevin C Johnson, An-Chi Tien, Jun Jiang, et al.
Page
of 3